The National Agency for Food and Drug Administration and Control has alerted Nigerians to the recall of Mivacron and Nimbex injections over safety concerns.
The agency, in a post on its X handle on Monday, said the affected products were manufactured by Aspen Pharmacare Asia Limited.
It explained that the recall followed safety concerns flagged by the Hong Kong Department of Health.
According to NAFDAC, one batch of Mivacron Injection 0.2 per cent and five batches of Nimbex Injection 2mg/mL are affected by the recall.
“The recall was made as a precautionary measure due to potential quality issues identified by the manufacturer,” NAFDAC said.
The agency stated that investigations showed deficiencies in the company’s manual visual inspection process, adding that not all glass particles in the ampoules were likely detected, prompting a voluntary market recall.
The injections, which contain mivacurium and cisatracurium, are prescription medicines used as adjuncts to general anaesthesia.
NAFDAC urged healthcare professionals and members of the public to report suspected substandard medicines to any of its offices nationwide or through its e-reporting platforms.
(Punch)
